|
Cricetidae
|
|
ILX:0102632
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cricetinae
|
|
ILX:0102633
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cricetulus
|
|
ILX:0102634
|
5
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cricetulus griseus
|
|
ILX:0102635
|
5
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cricothyroid muscle
|
Muscle of the larynx that influences glottic position by tilting the thyroid cartilage on the cricoid cartilage
|
ILX:0102636
|
10
|
scicrunch
|
06/23/2020
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Crista Junction
|
Tubular structures of relatively uniform size that connect mitochondrial cristae to the inner mitchondrial membrane (Perkins and Ellisman, 2003).
|
ILX:0102637
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cristae Quality
|
Refers to the morphology of mitochondrial cristae.
|
ILX:0102638
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Critical period
|
a limited time in which an event can occur, usually to result in some kind of transformation; in developmental psychology and developmental biology, it is a time in the early stages of an organisma's life during which it displays a heightened sensitivity to certain environmental stimuli, and develops in particular ways due to experiences at this time.
|
ILX:0102639
|
4
|
scicrunch
|
08/24/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
troy sincomb |
|
Crockerinus
|
|
ILX:0102640
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cromoglicate
|
A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. (PubChem) Pharmacology: Cromoglicate or cromolyn (USAN), a synthetic compound, inhibits antigen-induced bronchospasms and, hence, is used to treat asthma and allergic rhinitis. Cromoglicate is used as an ophthalmic solution to treat conjunctivitis and is taken orally to treat systemic mastocytosis and ulcerative colitis. Mechanism of action: Cromoglicate inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. Cromoglicate also may reduce the release of inflammatory leukotrienes. Cromoglicate may act by inhibiting calcium influx. Drug type: Approved. Small Molecule. Drug category: Anti-Asthmatic Agents
|
ILX:0102641
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cross Section Diameter Major
|
Maximum diameter of a cross section through structure, assumed to be the maximum diameter in the case of spherical structures like vesicles. Use this field when entering only a single cross section value where the structure is assumed to be spherical.
|
ILX:0102642
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cross Section Diameter Minor
|
Minimum diameter of a cross section through structure.
|
ILX:0102643
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Crotamiton
|
Crotamiton is a scabicidal and antipruritic agent available as a cream or lotion for topical use only. It is a colorless to slightly yellowish oil, having a faint amine-like odor. It is miscible with alcohol and with methanol. Pharmacology: Crotamiton is usually used to treat pruritis (itching of the skin) caused by scabies or sunburn. Crotamiton relieves itching by producing what is called a counter-irritation. As crotamiton evaporates from the skin, it produces a cooling effect. This cooling effect helps to divert your body's attention away from the itching. Due to this cooling effect it is also effective for the relief of sunburn. The drug is also believed to kill scabies through an unknown mechanism. Mechanism of action: Crotamiton relieves itching by producing what is called a counter-irritation. As crotamiton evaporates from the skin, it produces a cooling effect. This cooling effect helps to divert your body's attention away from the itching. Drug type: Approved. Small Molecule. Drug category: Antiparasitic Agents. Antipruritics. Pesticides. Scabicides
|
ILX:0102644
|
4
|
scicrunch
|
08/24/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
troy sincomb |
|
Crowded
|
A quality inhering in a bearer by virtue of being overfilled.
|
ILX:0102645
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Crus 1 of ABA 2009
|
|
ILX:0102646
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Crus 2 of ABA 2009
|
|
ILX:0102647
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Crustacea
|
|
ILX:0102648
|
4
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |
|
Cryptenamine
|
Cryptenamine is a mixture of closely related hypotensive alkaloids from Veratrum album (Liliaceae). It has been used in the treatment of hypertension but has largely been replaced by drugs with fewer adverse effects. Cryptenamine has a marked and re-producible depressor effect when given intravenously to hypertensive patients, however the mechanism of action is not known. Pharmacology: Cryptenamine is a mixture of closely related hypotensive alkaloids from Veratrum album (Liliaceae). It has been used in the treatment of hypertension but has largely been replaced by drugs with fewer adverse effects. Mechanism of action: Cryptenamine has a marked and re-producible depressor effect when given intravenously to hypertensive patients, however the mechanism of action is not known. Some evidence has suggested that cryptenamine acts in a similar fashion to atropine, which lowers the rest and digest" activity of all muscles and glands regulated by the parasympathetic nervous system. This occurs because atropine is a competitive inhibitor of the muscarinic acetylcholine receptors (acetylcholine is the neurotransmitter used by the parasympathetic nervous system). Therefore muscarinic acetylcholine receptors will be listed as experimental targets for cryptenamine. Drug type: Approved. Small Molecule. Drug category: Antihypertensive Agents"
|
ILX:0102649
|
4
|
scicrunch
|
08/24/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
troy sincomb |
|
CSIRO
|
CSIRO, the Commonwealth Scientific and Industrial Research Organisation, is Australia's national science agency and one of the largest and most diverse research agencies in the world.National Research Flagships: Large-scale, long-term, multidisciplinary science to address Australia's major national challenges and opportunities.Divisions: CSIRO expertise is organised into 14 research areas:* Animal, Food and Health Sciences* Astronomy and Space Science* Earth Science and Resource Engineering* Ecosystem Sciences* Energy Technology* Food & Nutritional Sciences* ICT Centre* Land and Water* Livestock Industries* Marine and Atmospheric Research* Materials Science & Engineering* Mathematics, Informatics and Statistics* Plant Industry* Process Science and EngineeringNational Facilities: CSIRO manages national facilities and collections that are opened to researchers around Australia and overseas.
|
ILX:0102650
|
5
|
scicrunch
|
08/24/2018
|
scicrunch |
term |
12/08/2016 |
-2 |
NeuroLex |
troy sincomb |
|
CT-proET-1
|
Carboxy terminus of prohormone endothelin-1
|
ILX:0102651
|
3
|
scicrunch
|
06/18/2018
|
scicrunch |
term |
12/08/2016 |
0 |
NeuroLex |
NeuroLex |